Radiotherapy results in higher diabetes risk for some childhood cancer survivors

August 22, 2012

The study – which analysed more than 2500 patient questionnaires and medical records from French and British people who had cancer in childhood but survived for at least 20 years after undergoing treatment – is the first to link diabetes and radiation.

The researchers used sophisticated mathematical modelling techniques, along with information about how the patient would have been likely to be treated when they received radiotherapy, to reconstruct exactly how and where the respondents were exposed to radiation when treated.

Overall, at age 45, 2.3% patients who had not received radiotherapy had been diagnosed with , compared with 6.6% of those people who had been treated for childhood cancer with radiotherapy. By reconstructing how the radiotherapy would have been applied, the researchers were able to discover that when the tail of the pancreas was exposed to radiation, patients were significantly more likely to be diagnosed with diabetes later in life, although radiation exposure to other parts of the pancreas did not affect diabetes rates. The authors speculate that this is because the tail of the pancreas contains a type of cell involved in insulin production.

They also found that higher doses of radiation resulted in a greater likelihood of acquiring diabetes in later life, with patients who received an average radiation dose of 24.2 Grays to the tail of the pancreas being 12.6 times more likely to be diagnosed with diabetes within 20 years of completing , compared to patients who did not receive radiation therapy.

The type of cancer treated affected later diabetes risk—14.7% of patients who had been treated for nephroblastoma (kidney cancer) had been diagnosed with diabetes by age 45, compared to an average of 3.1% for other types of cancer included in the study. Radiation therapy for nephroblastoma often focuses in the abdominal area, which increases the likelihood that the tail of the pancreas will be exposed to radiation.

Dr Florent de Vathaire of the Centre for Epidemiology and Public Health (CESP) of INSERM at the Gustave Roussy Institute in France, one of the authors of the paper, said: "The pancreas needs to be regarded as a critical organ when planning radiation therapy, particularly in children. Until now, the pancreas was one of the few organs not considered at risk of normal tissue complication in the French and the UK national guidelines for cancer radiation therapy. Our findings indicate that the is an organ at risk during radiation therapy and has to be contoured when planning treatment, to ensure a radiation dose of as low as possible."

In a linked Comment, Kevin Oeffinger of the Memorial Sloan-Kettering Cancer Center, New York, said, "The clinical implications of this study are important, since radiation remains an integral part of therapy for many children with Wilms' tumour [a type of kidney ] or neuroblastoma. Diabetes is a major risk factor for all-cause and cardiovascular mortality. Further study is therefore needed to clarify the mechanisms underlying diabetes after abdominal radiation. Understanding these mechanisms will, hopefully, result in the development of targeted interventions that will lead to a reduction in risk in this population."

Explore further: After chest radiation, girls at greater risk for early breast cancer: study

More information: www.thelancet.com/journals/lan … (12)70323-6/abstract

Related Stories

After chest radiation, girls at greater risk for early breast cancer: study

June 4, 2012
(HealthDay) -- Girls who receive radiation to the chest to treat childhood cancer, even those getting lower doses, have a high risk of developing breast cancer at a young age, according to a new study.

IMRT cuts GI side effects from prostate cancer in half vs. 3D-CRT

June 1, 2011
Intensity modulated radiation therapy, a newer, more precise form of radiation therapy, causes fewer gastrointestinal side effects when combined with hormone therapy than using three-dimensional radiation therapy, according ...

Higher radiation dose does not help lung cancer patients live longer

October 3, 2011
A higher dose of radiation (74 Gy) does not improve overall survival for non-small cell lung cancer that has spread to the lymph nodes, compared to the standard radiation dose (60 Gy), according to an interim analysis of ...

Radiation plus chemotherapy provides long-term positive results for head and neck cancer patients

January 26, 2012
A select subgroup of advanced head and neck cancer patients treated with radiation therapy plus the chemotherapy drug cisplatin had more positive outcomes than patients treated with radiation therapy alone and continued to ...

Recommended for you

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

Popular immunotherapy target turns out to have a surprising buddy

August 16, 2017
The majority of current cancer immunotherapies focus on PD-L1. This well studied protein turns out to be controlled by a partner, CMTM6, a previously unexplored molecule that is now suddenly also a potential therapeutic target. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.